Rep. Gilbert Ray Cisneros, Jr. Buys Globus Medical, Inc. (NYSE:GMED) Shares

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Globus Medical, Inc. (NYSE:GMED). In a filing disclosed on April 07th, the Representative disclosed that they had bought between $1,001 and $15,000 in Globus Medical stock on March 3rd.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of MACOM Technology Solutions (NASDAQ:MTSI) on 3/27/2026.
• Purchased $1,001 – $15,000 in shares of StandardAero (NYSE:SARO) on 3/27/2026.
• Purchased $1,001 – $15,000 in shares of FirstService (NASDAQ:FSV) on 3/27/2026.
• Sold $1,001 – $15,000 in shares of Charles Schwab (NYSE:SCHW) on 3/27/2026.
• Sold $1,001 – $15,000 in shares of Advanced Energy Industries (NASDAQ:AEIS) on 3/27/2026.
• Sold $1,001 – $15,000 in shares of Flex (NASDAQ:FLEX) on 3/27/2026.
• Purchased $1,001 – $15,000 in shares of LPL Financial (NASDAQ:LPLA) on 3/27/2026.
• Purchased $1,001 – $15,000 in shares of DoorDash (NASDAQ:DASH) on 3/27/2026.
• Sold $1,001 – $15,000 in shares of Viavi Solutions (NASDAQ:VIAV) on 3/27/2026.
• Purchased $15,001 – $50,000 in shares of Fabrinet (NYSE:FN) on 3/27/2026.

Globus Medical Price Performance

Shares of NYSE GMED traded down $0.89 during trading on Friday, hitting $90.51. 1,028,059 shares of the company were exchanged, compared to its average volume of 1,262,016. The company has a market cap of $12.24 billion, a price-to-earnings ratio of 22.97, a PEG ratio of 2.15 and a beta of 1.09. Globus Medical, Inc. has a 1 year low of $51.79 and a 1 year high of $101.40. The firm’s fifty day moving average price is $88.68 and its 200 day moving average price is $82.19.

Globus Medical (NYSE:GMED) last issued its earnings results on Tuesday, February 24th. The medical device company reported $1.28 EPS for the quarter, topping the consensus estimate of $1.06 by $0.22. The company had revenue of $826.42 million for the quarter, compared to analyst estimates of $803.29 million. Globus Medical had a net margin of 18.30% and a return on equity of 12.57%. The business’s revenue was up 25.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.84 EPS. On average, research analysts forecast that Globus Medical, Inc. will post 3.44 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in GMED. Hsbc Holdings PLC acquired a new position in Globus Medical in the 4th quarter valued at about $2,254,000. Rockefeller Capital Management L.P. raised its stake in Globus Medical by 52.5% in the 4th quarter. Rockefeller Capital Management L.P. now owns 11,738 shares of the medical device company’s stock valued at $1,025,000 after purchasing an additional 4,042 shares during the last quarter. Corient Private Wealth LLC raised its stake in Globus Medical by 7.1% in the 4th quarter. Corient Private Wealth LLC now owns 51,372 shares of the medical device company’s stock valued at $4,487,000 after purchasing an additional 3,390 shares during the last quarter. MidFirst Bank acquired a new position in Globus Medical in the 4th quarter valued at about $354,000. Finally, Pacer Advisors Inc. raised its stake in Globus Medical by 20.4% in the 4th quarter. Pacer Advisors Inc. now owns 33,177 shares of the medical device company’s stock valued at $2,897,000 after purchasing an additional 5,617 shares during the last quarter. Institutional investors and hedge funds own 95.16% of the company’s stock.

Analysts Set New Price Targets

GMED has been the subject of several research reports. Barclays lifted their price target on Globus Medical from $118.00 to $123.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 25th. Royal Bank Of Canada lifted their price target on Globus Medical from $92.00 to $100.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. BTIG Research reaffirmed a “neutral” rating on shares of Globus Medical in a research note on Tuesday, December 30th. Wall Street Zen raised Globus Medical from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 3rd. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $115.00 price target (up from $90.00) on shares of Globus Medical in a research note on Thursday, January 8th. Three equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, Globus Medical currently has a consensus rating of “Moderate Buy” and a consensus target price of $104.36.

Insiders Place Their Bets

In related news, EVP Kelly Huller sold 20,000 shares of the business’s stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $94.50, for a total value of $1,890,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 18.51% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Globus Medical Company Profile

Globus Medical, Inc (NYSE:GMED) is a leading medical device company specializing in musculoskeletal solutions for spine and orthopaedic applications. Founded in 2003 by David C. Paul and headquartered in Audubon, Pennsylvania, the company develops, manufactures and markets implantable devices and surgical instruments designed to treat spinal disorders and promote bone healing. Its product portfolio encompasses solutions for minimally invasive and open surgical procedures, including interbody fusion devices, pedicle screw systems, and biologics used to enhance fusion outcomes.

In addition to its core spine business, Globus Medical has expanded into robotics and navigation systems to support precision and efficiency in the operating room.